CAMBRIDGE ENTERPRISE Terry joined Cambridge Enterprise as Commercialisation Director in 2018. He was previously the Head of Intellectual Property and Commercial Research at Guy’s and St Thomas’ Hospital for over 10 years, having founded and grown a technology transfer department that commercialised NHS inventions from ‘bedside to business’.
Terry has commercialised a variety of technologies including medical devices, software, imaging technologies, laboratory products, novel formulations, in vitro diagnostics and service based IP. He has also been involved in the creation of novel partnerships for the National Health Service such as Viapath (a £500M pathology joint venture with Serco) and Essentia Trading Ltd (a facilities spin-out company). Terry also supported the formation of technology-based spin-out companies including Cydar and SpOtOn Clinical Diagnostics amongst others and has served as a Director for several of the Hospital’s spin-out companies. Terry was also responsible for founding a Proof of Concept investment fund and setting up a commercial research and consultancy service within the NHS to interface with industry. Prior to this Terry was part of a team responsible for the merger of the London NHS Innovation hubs and has a background in immunology, gene silencing and stem cell research.
